Insights for Safer Medicines and Smarter Traceability
At Synchrypt, we care about people’s health and well-being. Through expert insights, medicine verification updates, and supply chain innovation, we help build a safer and more transparent healthcare ecosystem for everyone.
-
In Pakistan, Cancer Patients Face Rising Drug Prices and Counterfeit Medicines
ISLAMABAD — Pakistan’s growing cancer crisis has exposed the fragile state of its pharmaceutical supply chain, where shortages, rising prices, […] Read More →
-
FDA’s New Import Alert on GLP-1 Ingredients: What It Means for Drug Safety and Counterfeit Risks
Blog Post On September 5, 2025, Reuters reported that the U.S. FDA issued an import alert on GLP-1 ingredients—a move […] Read More →
-
Drug Shortages, Counterfeit Medicines, and the Urgent Need for Stronger Supply Chain Security
A Wake-Up Call from Recent U.S. Policy Moves On September 3, 2025, Global Biodefense reported on a new executive order […] Read More →
-
The Hidden Danger of Counterfeit Fentanyl: Why Stronger Verification Is Urgent
A Global Health Warning from WHO On August 29, 2025, the World Health Organization (WHO) issued a medical product alert […] Read More →
-
The Hidden Threat of Counterfeit Medicines: What the Latest EUIPO–OECD Report Reveals
The global trade in counterfeit medicines is growing at an alarming pace, and the latest report published by the European […] Read More →
-
Counterfeit Botox Raises Alarms: Why Medicine Verification Matters More Than Ever
The U.S. Food and Drug Administration (FDA) recently issued a warning about counterfeit Botox discovered in multiple states. This alarming […] Read More →